The	The	DT	B-NP	O
human	human	JJ	I-NP	O
intestine	intestine	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
vast	vast	JJ	I-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
balance	balance	NN	I-NP	O
is	be	VBZ	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
several	several	JJ	B-NP	O
factors	factor	NNS	I-NP	O
.	.	.	O	O

Antibiotics	Antibiotic	NNS	B-NP	O
affect	affect	VBP	B-VP	O
microfloral	microfloral	JJ	B-NP	O
balance	balance	NN	I-NP	O
and	and	CC	O	O
allow	allow	VB	B-VP	O
naturally	naturally	RB	B-NP	O
opportunistic	opportunistic	JJ	I-NP	O
organisms	organism	NNS	I-NP	O
to	to	TO	B-PP	O
multiply.	multiply.	JJ	B-NP	O
Azithromycin	Azithromycin	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
widely	widely	RB	I-NP	O
used	use	VBN	I-NP	O
macrolide	macrolide	NN	I-NP	O
antibiotic	antibiotic	NN	I-NP	O
,	,	,	O	O
active	active	JJ	B-ADJP	O
against	against	IN	B-PP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
pathogens	pathogen	NNS	B-NP	O
including	include	VBG	B-PP	O
Pseudomonas	Pseudomonas	NN	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O
and	and	CC	O	O
Staphylococcus	Staphylococcus	FW	B-NP	O
aureus	aureus	FW	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	I-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
cystic	cystic	JJ	B-NP	O
fibrosis	fibrosis	NN	I-NP	O
patients.	patients.	NN	I-NP	O
The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
probiotics	probiotic	NNS	B-NP	O
has	have	VBZ	B-VP	O
advantages	advantage	NNS	B-NP	O
in	in	IN	B-PP	O
gastrointestinal	gastrointestinal	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
infectious	infectious	JJ	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
and	and	CC	I-NP	O
imbalance	imbalance	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
research	research	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
azithromycin	azithromycin	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
intestinal	intestinal	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
of	of	IN	B-PP	O
Sprague	Sprague	NNP	B-NP	O
Dawley	Dawley	NNP	I-NP	O
rats	rat	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
Lactobacillus	Lactobacillus	NN	B-NP	O
acidophilus	acidophilus	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
restoration	restoration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
balance	balance	NN	I-NP	O
by	by	IN	B-PP	O
employing	employ	VBG	B-VP	O
molecular	molecular	JJ	B-NP	O
and	and	CC	I-NP	O
cultural	cultural	JJ	I-NP	O
techniques	technique	NNS	I-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

PCR	PCR	NN	B-NP	O
with	with	IN	B-PP	O
universal	universal	JJ	B-NP	O
primers	primer	NNS	I-NP	O
targeting	target	VBG	B-VP	O
the	the	DT	B-NP	O
V3	V3	NN	I-NP	B-protein
region	region	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
16S	16S	NN	I-NP	B-DNA
rRNA	rRNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
DGGE	DGGE	NN	B-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
characterize	characterize	VB	I-VP	O
the	the	DT	B-NP	O
overall	overall	JJ	I-NP	O
intestinal	intestinal	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
composition	composition	NN	I-NP	O
.	.	.	O	O

Cultivable	Cultivable	JJ	B-NP	O
fecal	fecal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
count	count	NN	I-NP	O
using	use	VBG	B-VP	O
microbiological	microbiological	JJ	B-NP	O
media	medium	NNS	I-NP	O
and	and	CC	O	O
semi-quantitative	semi-quantitative	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
with	with	IN	B-PP	O
group-specific	group-specific	JJ	B-NP	O
primers	primer	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
utilized	utilize	VBN	I-VP	O
to	to	TO	I-VP	O
analyze	analyze	VB	I-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
and	and	CC	I-NP	O
probiotic	probiotic	JJ	I-NP	O
on	on	IN	B-PP	O
microflora	microflora	NNS	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
16S	16S	NN	B-NP	B-DNA
rRNA	rRNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
and	and	CC	O	O
fecal	fecal	JJ	B-NP	O
aerobic	aerobic	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
following	follow	VBG	B-PP	O
azithromycin	azithromycin	NN	B-NP	O
administration	administration	NN	I-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
elimination	elimination	NN	B-NP	O
of	of	IN	B-PP	O
non-pathogenic	non-pathogenic	JJ	B-NP	O
Escherichia	Escherichia	FW	I-NP	O
coli	coli	FW	I-NP	O
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
restored	restore	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
probiotic	probiotic	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
from	from	IN	B-PP	O
PCR	PCR	NN	B-NP	O
with	with	IN	B-PP	O
group-specific	group-specific	JJ	B-NP	O
primers	primer	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
Bacteroides	Bacteroide	NNS	B-NP	O
sp	sp	NN	I-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
and	and	CC	I-NP	O
probiotic	probiotic	JJ	I-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
nearly	nearly	RB	I-VP	O
eliminated	eliminate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
semi-quantitative	semi-quantitative	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
Enterobacteriaceae	Enterobacteriaceae	NNS	B-NP	O
were	be	VBD	B-VP	O
nearly	nearly	RB	B-NP	O
the	the	DT	I-NP	O
same	same	JJ	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
probiotic	probiotic	JJ	I-NP	O
group	group	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
Bifidobacterium	Bifidobacterium	NN	B-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
probiotic	probiotic	JJ	I-NP	O
group	group	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0	0	CD	B-NP	O
.	.	.	O	O

05	05	LS	B-LST	O
)	)	)	O	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

Azithromycin-induced	Azithromycin-induced	JJ	B-NP	O
dysbiosis	dysbiosis	NN	I-NP	O
can	can	MD	B-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
prolonged	prolonged	JJ	B-NP	O
deleterious	deleterious	JJ	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
host	host	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP
present	present	JJ	I-NP
study	study	NN	I-NP
revealed	reveal	VBD	B-VP
that	that	IN	B-SBAR
the	the	DT	B-NP
use	use	NN	I-NP
of	of	IN	B-PP
lactic	lactic	JJ	B-NP
acid	acid	NN	I-NP
bacteria	bacteria	NNS	I-NP
particularly	particularly	RB	B-ADVP
L.	L.	NNP	B-NP
acidophilus	acidophilus	NN	I-NP
helped	help	VBD	B-VP
to	to	TO	I-VP
restore	restore	VB	I-VP
intestinal	intestinal	JJ	B-NP
microfloral	microfloral	JJ	I-NP
balance	balance	NN	I-NP
.	.	.	O	O
